Search hospitals > Rhode Island > Providence
Women and Infants Hospital
Claim this profileProvidence, Rhode Island 02905
Global Leader in Cancer
Global Leader in Ovarian Cancer
Conducts research for Fallopian Tube Cancer
Conducts research for Recurrence
Conducts research for Ovarian Tumors
349 reported clinical trials
24 medical researchers
Summary
Women and Infants Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Cancer, Ovarian Cancer, Fallopian Tube Cancer, Recurrence, Ovarian Tumors and other specialties. Women and Infants Hospital is involved with conducting 349 clinical trials across 361 conditions. There are 24 research doctors associated with this hospital, such as Cara Mathews, MD, Katina M. Robison, William M. Sikov, and Paul A. DiSilvestro.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Ovarian Cancer
Global LeaderStage IV
Stage III
BRCA1 positive
Top PIs
Cara Mathews, MDWomen and Infants Hospital1 year of reported clinical research
Expert in Endometrial Cancer
Studies Ovarian Cancer
22 reported clinical trials
44 drugs studied
Katina M. RobisonWomen and Infants Hospital6 years of reported clinical research
Studies Ovarian Cancer
Studies Cancer
12 reported clinical trials
22 drugs studied
William M. SikovWomen and Infants Hospital5 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
11 reported clinical trials
30 drugs studied
Paul A. DiSilvestroWomen and Infants Hospital12 years of reported clinical research
Studies Cancer
Studies Ovarian Cancer
8 reported clinical trials
39 drugs studied
Clinical Trials running at Women and Infants Hospital
Breast Cancer
Ovarian Cancer
Endometrial Cancer
Cancer
Endometrial Adenocarcinoma
Fallopian Tube Cancer
Recurrence
Adenocarcinoma
Ovarian Tumors
Serous Cystadenocarcinoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Women and Infants Hospital?
Women and Infants Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Cancer, Ovarian Cancer, Fallopian Tube Cancer, Recurrence, Ovarian Tumors and other specialties. Women and Infants Hospital is involved with conducting 349 clinical trials across 361 conditions. There are 24 research doctors associated with this hospital, such as Cara Mathews, MD, Katina M. Robison, William M. Sikov, and Paul A. DiSilvestro.
Where is Women and Infants Hospital located?
To reach Women and Infants Hospital in Providence, Rhode Island:
1. Take Interstate 95 South to Exit 19, Eddy Street.
2. Bear left towards Eddy Street, then turn right onto Eddy Street at the light.
3. At the first set of lights on Eddy Street, turn right onto Dudley Street. The hospital is approximately 0.2 miles on the right.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Women and Infants Hospital, please contact (401) 274-1122 x42120, available Monday through Friday, 9 a.m. to 5 p.m. If you're facing difficulties affording your hospital bill, you may qualify for medical bill relief or charity care.
What insurance does Women and Infants Hospital accept?
Women and Infants Hospital accepts a broad spectrum of insurance plans, such as Advantage EPO, Aetna APCN Open Access, Aetna Select, and more. It is advised to verify coverage with your insurance provider. The hospital provides a comprehensive range of healthcare services, including gynecologic cancer care, obstetrics and gynecology, urogynecology, laboratory services, diagnostic imaging, anesthesiology, physical therapy, pelvic health rehabilitation, emergency care, and hearing services for both children and adults.
What awards or recognition has Women and Infants Hospital received?
Women and Infants Hospital in Providence, Rhode Island, is nationally recognized for its research in newborn hearing screening, Down Syndrome detection, and diabetes in pregnancy. It serves as a major teaching affiliate of The Warren Alpert Medical School of Brown University, focusing on obstetrics, gynecology, and newborn pediatrics. The hospital's researchers are supported by grants from various agencies and foundations, including the National Institutes of Health.